Allurion Technologies (ALURW) Income from Continuing Operations (2022 - 2026)

Allurion Technologies (ALURW) reported Income from Continuing Operations of 6095000.0 for Q1 2026, down 306.06% on a YoY basis from 2957838.67 in Q1 2025, and down 126.48% quarter-over-quarter from 23020000.0 in Q4 2025.

Allurion Technologies (ALURW) Income from Continuing Operations (2022 - 2026) Analysis & Trends

Allurion Technologies has reported Income from Continuing Operations for 5 years, with the latest figure at 6095000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Income from Continuing Operations fell 306.06% year-over-year to 6095000.0; the trailing twelve-month figure through Mar 2026 stood at 4294000.0 (down 24.5% YoY), and the FY2025 full-year result was 347000.0, up 179.84% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 6095000.0, down from 23020000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 62043000.0 in Q4 2023, with the low at 21996000.0 in Q2 2023.
  • Historically, Income from Continuing Operations has averaged 115875.0 across 5 years, with a median of 5750000.0 in 2022.
  • Annual changes were most pronounced in 2023 — Income from Continuing Operations sank 306.96% — and 2025, when it surged 1102.61%.
  • Allurion Technologies' Income from Continuing Operations stood at 25962000.0 in 2022, then soared by 138.98% to 62043000.0 in 2023, then tumbled by 103.7% to 2296000.0 in 2024, then surged by 1102.61% to 23020000.0 in 2025, then tumbled by 126.48% to 6095000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 6095000.0 (Q1 2026), 23020000.0 (Q4 2025), and 11884000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.08 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 745.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 380.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 273.95 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 411.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 220.30 Mn
10 Allurion Technologies - - 1.23 Mn -6.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.10 Mn
Dec 31, 2025 23.02 Mn
Sep 30, 2025 -11.88 Mn
Jun 30, 2025 -9.34 Mn
Mar 31, 2025 -1.50 Mn
Dec 31, 2024 -2.30 Mn
Sep 30, 2024 8.71 Mn
Jun 30, 2024 -8.36 Mn
Mar 31, 2024 2.00 Mn
Dec 31, 2023 62.04 Mn
Sep 30, 2023 -21.63 Mn
Jun 30, 2023 -22.00 Mn
Mar 31, 2023 -17.80 Mn
Dec 31, 2022 25.96 Mn
Sep 30, 2022 -13.57 Mn
Jun 30, 2022 -5.41 Mn